Kiora Pharmaceuticals Inc (KPRX) Institutional Ownership

Ownership Summary

Kiora Pharmaceuticals Inc (NASDAQ:KPRX) is held by 19 institutional investors per 13F filings through December 2025.

• Collectively, these holders controlled 20.1% of Kiora Pharmaceuticals's outstanding shares in December 2025, up from 14.1% in September 2025.
• They increased total shares held in Kiora Pharmaceuticals by 45.9% from the prior quarter, while the number of investors in KPRX increased 18.75% year over year.
• Of these 19 holders, 9 added to their stakes in Kiora Pharmaceuticals, 5 trimmed positions, and 5 made no changes.
• Combined, these investors held 875.89K shares in KPRX for December 2025, up by 275.56K shares quarter on quarter, and down 634.11K shares year over year.
• As of December 31, 2025, ADAR1 Capital Management, LLC held the largest stake in Kiora Pharmaceuticals with 335.88K shares, accounting for 7.7% of total shares outstanding.
• The most significant purchases of KPRX for the quarter ending December 2025 came from ADAR1 Capital Management, LLC (167.94K), Alyeska Investment Group, L.P. (76.9K), DRW Securities, LLC (73.42K), VANGUARD GROUP INC (12.18K), XTX Topco Ltd (11.97K).
• Top sellers of KPRX stock for the quarter ending December 2025 included Nantahala Capital Management, LLC (50.27K), CITADEL ADVISORS LLC (22.19K), Stonepine Capital Management, LLC (9.45K), UBS Group AG (452), Bank Of America Corp /De/ (21).
• Kiora Pharmaceuticals's 10 largest shareholders as of December 2025 include ADAR1 Capital Management, LLC (335.88K), Stonepine Capital Management, LLC (131.14K), DRW Securities, LLC (110.28K), Nantahala Capital Management, LLC (106.16K), Alyeska Investment Group, L.P. (76.9K), VANGUARD GROUP INC (33.09K), CITADEL ADVISORS LLC (22.38K), GEODE CAPITAL MANAGEMENT, LLC (22.01K), RENAISSANCE TECHNOLOGIES LLC (21.2K), XTX Topco Ltd (11.97K) per Business Quant data.